Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent Epithelial Ovarian Cancer: Results from a Retrospective Study on Prospectively Established Database()

BACKGROUND: Despite the best standard treatment, optimal cytoreductive surgery (CRS) and platinum/taxane-based chemotherapy, prognosis of advanced epithelial ovarian carcinoma (EOC) remains poor. Recently, CRS plus hyperthermic intraperitoneal chemotherapy (HIPEC) has been developed to treat periton...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jian-Hua, Ji, Zhong-He, Yu, Yang, Wu, Hai-Tao, Huang, Chao-Qun, Zhang, Qian, Yang, Xiao-Jun, Yonemura, Yutaka, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833965/
https://www.ncbi.nlm.nih.gov/pubmed/27084429
http://dx.doi.org/10.1016/j.tranon.2016.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833965/
https://www.ncbi.nlm.nih.gov/pubmed/27084429
http://dx.doi.org/10.1016/j.tranon.2016.02.002

Ejemplares similares